CellCarta Acquires Reveal Biosciences
May 11, 2021
CellCarta has acquired Reveal Biosciences, a San Diego–based computational pathology company specializing in AI-driven quantitative pathology and digital image analysis. The acquisition adds Reveal's imageDx platform and AI-based pathology capabilities to CellCarta's histological biomarker and precision medicine services, broadening its AI-enabled multi-omic analysis offerings for biopharmaceutical research and clinical trials.
- Buyers
- CellCarta
- Targets
- Reveal Biosciences
- Industry
- Healthcare Services
- Location
- California, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Discovery Life Sciences Acquires ReachBio Research Labs
April 11, 2023
Biotechnology
Discovery Life Sciences has acquired Seattle-based ReachBio Research Labs to expand its cell biology, toxicology and drug screening capabilities. The acquisition strengthens Discovery's preclinical development and multi-omics service offering, enabling customers to access a broader set of predictive cell-based assays for hematologic diseases, immunology, oncology and cell & gene therapy programs.
-
CellCarta Acquires Biogazelle
December 14, 2021
Biotechnology
CellCarta has acquired Biogazelle, a Ghent-based leader in digital PCR (dPCR), qPCR and RNASeq assay development, to strengthen and expand its genomic capabilities. The acquisition creates a Center of Excellence for complex genomic biomarker assay development within CellCarta and broadens its service offering for pharmaceutical and biotech clients across discovery and clinical stages.
-
Carta Healthcare Acquires Realyze Intelligence from UPMC Enterprises
December 9, 2024
Healthcare Services
Carta Healthcare has acquired Realyze Intelligence, a UPMC Enterprises portfolio company. The deal brings Realyze's clinician-trained AI for rapid EHR-based oncology trial matching and data abstraction into Carta's AI-powered clinical data platform to accelerate clinical trial matching and registry abstraction.
-
K1 Investment Management Acquires Reveal; Reveal Merges with Brainspace
January 26, 2021
AI & Machine Learning
K1 Investment Management has invested in the combined Reveal and Brainspace organization, acquiring Reveal from Gallant Capital Partners and merging Reveal with Brainspace to create a leading AI-powered eDiscovery platform. The combined company will receive more than $200 million of investment from K1 to accelerate product development, expand sales and marketing, and grow R&D and data science capabilities.
-
Reveal Acquires NexLP
August 11, 2020
AI & Machine Learning
Reveal Data Corporation has acquired NexLP, an AI-driven eDiscovery software provider, and will integrate NexLP's Story Engine AI and data science team into Reveal's review platform. Jay Leib, NexLP co-founder and CEO, joins Reveal as EVP of Innovation & Strategy; terms were not disclosed and Reveal — which is majority-owned by Gallant Capital Partners — worked with Houlihan Lokey and Stradling Yocca Carlson & Rauth on the transaction.
-
Ashling Partners Acquires Reveal Group
October 18, 2024
Consulting
Ashling Partners has acquired Reveal Group to expand its Multimodal Automation capabilities and add Reveal Group's proprietary Reveal RoboSuite automation acceleration tools. The deal brings Reveal's Intelligent Automation consulting expertise and North American client relationships (healthcare, banking/financial services, manufacturing) into Ashling's global delivery model and supports Ashling's expansion into Canada.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.